Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALMS | Class A Common Stock | Conversion of derivative security | +1.7M | 1.7M | Jul 1, 2024 | By Samsara BioCapital, L.P. | F1, F2 | |||
transaction | ALMS | Class A Common Stock | Disposed to Issuer | -1.7M | -100% | 0 | Jul 1, 2024 | By Samsara BioCapital, L.P. | F2, F3 | ||
transaction | ALMS | Common Stock | Award | +1.7M | 1.7M | Jul 1, 2024 | By Samsara BioCapital, L.P. | F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALMS | Series C Preferred Stock | Conversion of derivative security | $0 | -1.7M | -100% | $0.00* | 0 | Jul 1, 2024 | Class A Common Stock | 1.7M | By Samsara BioCapital, L.P. | F1, F2 |
Id | Content |
---|---|
F1 | Upon closing of the Issuer's initial public offering, each share of Series C Preferred Stock (the "Preferred Stock") automatically converted on a 4.675-to-one basis into shares of Class A Common Stock. The Preferred Stock had no expiration date. |
F2 | Shares are held directly by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara GP") is the general partner of Samsara LP. The Reporting Person, as the managing member of Samsara GP, shares voting and investment authority over the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein. |
F3 | Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of voting Common Stock. |